An in silico Approach for Identification of Novel Natural Selective ALR2 Inhibitors from Cynomorium songaricum for Treating Diabetic Complications
These promising <i>iin silico</i>i findings suggest that CID: 8468 and CID: 135 merit further evaluation through <i>iin vitro, in vivo</i>i, and clinical studies as potential selective inhibitors for the treatment of diabetic complications.
Authors
- Emad Abboh Abdallah Abboh
- Talal Alharazi (ORCID: https://orcid.org/0000-0002-3371-0477)
- Khalid Alshaghdali (ORCID: https://orcid.org/0009-0000-3014-883X)
- Munazzah Tasleem (ORCID: https://orcid.org/0000-0002-4811-2154)
- Amre Nasr (ORCID: https://orcid.org/0000-0001-5010-7322)
- Mοhd Saeed (ORCID: https://orcid.org/0000-0003-3443-386X)
- Dharmendra Kumar Yadav (ORCID: https://orcid.org/0000-0003-1102-1993)
- Gamal Mohamed Elawad Ahmed
- Kamal Yassin
- Tolgahan Acar (ORCID: https://orcid.org/0000-0002-5497-8528)
Institutions
- Gachon University (KR)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdulaziz Medical City (SA)
- University of Ha'il (SA)
- Saveetha University (IN)
- Umeå University (SE)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-06-13
- DOI
- https://doi.org/10.2174/0113816128372035250526145207
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00